GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
650
c/survodutide·posted 1 year ago by u/lyophile_lou

the biopsy thing finally clicked for me and I want to write it down

Caution Well Actually ×5

Something I noticed reading old threads that I have not seen said out loud.

The advice on hepatic fat in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with the same confidence.

I have listed what I think the current consensus is below. Correct me — that is the point of posting it.

820 up / 170 down83% upvoted10 commentsid 1tlepa5 Jan 2025

10 comments

7 in this archive, depth 3

best — the order this archive was captured in

u/cold_chromatogram_only87 points·1 year ago

You have restated the marketing copy. What is the actual substance here.

replysharereportpermalink
[deleted]34 points·1 year ago

[deleted]

replysharereportpermalink
u/mod_cold_roommod · c/coldchain16 points·1 year ago

MASH claims need the trial and the biopsy endpoint

replysharereportpermalink
u/camila_marchand54 points·1 year ago

the GLP-1/glucagon dual is glucagon, different from GIP/GLP-1

replysharereportpermalink
u/preservative_free_p36 points·1 year ago·edited

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

replysharereportpermalink
u/crosspost_bot_no0 points·1 year ago

I am going to push back on this slightly.

replysharereportpermalink
u/samir_falk19 points·1 year ago

glucagon co-agonism has a different safety story

replysharereportpermalink
About c/survodutide

Survodutide-specific discussion: glucagon-receptor co-agonism, the hepatic fat and MASH resolution data, and how the side-effect profile compares with GIP-based dual agonism. Small community, high signal.

12kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/survodutide
c/survodutide rules
  1. Glucagon co-agonism has a distinct safety story. Do not generalise from tirzepatide.
  2. MASH claims need the trial and the biopsy endpoint.
  3. Not approved. Descriptive posts only.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/incretin_ivyu/liver_enzyme_lizu/trialwatch_theo
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →